Plott Ronald Todd
SEC Form 4 insider trading activity
Plott Ronald Todd has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 30, 2026.
On the most recent filing, Plott Ronald Todd is listed as Director at Phio Pharmaceuticals Corp. Inside the rolling window, Plott Ronald Todd reported 3 open-market purchases totaling $27K in PHIO and no open-market sales. The largest disclosed transaction in the window is a purchase of 15,000 PHIO shares on Aug 19, 2026, worth $17K.
Companies traded
Other insiders at PHIO
Insider Buying
$27K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Plott Ronald Todd made?
Plott Ronald Todd has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Plott Ronald Todd trade?
Plott Ronald Todd has filed SEC Form 4 disclosures for 1 company, including PHIO.
When was Plott Ronald Todd's most recent SEC Form 4 filing?
Plott Ronald Todd's most recent SEC Form 4 filing on Tracefour is dated Sep 30, 2026.
What is Plott Ronald Todd's total buy and sell value in the current window?
Inside the rolling retention window, Plott Ronald Todd bought $27K and sold $0 based on SEC Form 4 filings.
What was Plott Ronald Todd's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 15,000 PHIO shares on 2026-08-19, worth $17K, per SEC Form 4 filings.